While ABCB1 siRNAs were able to restore drug sensitivity in daunorubicin-resistant gastric, hepatic, and pancreatic tumour cell lines [48,49], they showed little ability to restore drug sensitivity in paclitaxel-resistant PC-3-TxR prostate cancer cells [50]. Here, ABCB1 is linked to prostate carcinoma.